← Back to patent-cliff list
SCAI-005
Tier C — Watch / tradeSCAI-005
Scai Therapeutics
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：VEGFR
Indications (approved)：年龄相关性黄斑变性, 湿性年龄相关性黄斑变性
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SCAI-005?
Approved indications include: 年龄相关性黄斑变性, 湿性年龄相关性黄斑变性.
When does the SCAI-005 patent expire?
No public expiry year is available for SCAI-005 yet; this page updates once verified.
How do I get a quote for SCAI-005 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29